In order to analyze the molecular mechanism of CRABP2 regulating drug resistance in ovarian cancer, we conducted enrichment analysis on gene data from TCGA database, and found that CRABP2 may be involved in the metabolic regulation of ovarian cancer cells. This evidence concerns the gene CRABP2 and ovarian carcinoma.